Cost burden of viral respiratory infections: Issues for formulary decision makers

American Journal of Medicine

Volumn 112, Issue 6 SUPPL. 1, 2002, Pages 42-49

  Bertino, Joseph S ^a  

^a BASSETT HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; DOXYCYCLINE; NON PRESCRIPTION DRUG; PARACETAMOL; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; COST OF ILLNESS; DECISION MAKING; DIAGNOSTIC TEST; DRUG COST; DRUG INDUCED DISEASE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; LIVER FAILURE; MEDICAL EDUCATION; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RHINOVIRUS; SCHOOL; SEASONAL VARIATION; TIME; VIRUS INFECTION; WORK;

EID: 0037156398     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(01)01063-4     Document Type: Conference Paper

References (48)

1. The family physician's reasonable approach to upper respiratory tract infection care for this century
2. Measurements of the prevalence of viral infections
3. The common cold - Principles of judicious use of antimicrobial agents
4. Frequency and severity of infections in daycare
5. Trends in antimicrobial drug prescribing among office-based physicians in the United States
6. An evaluation of statewide strategies to reduce antibiotic overuse
7. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response
8. The economic burden of viral respiratory infection in the United States
9. Excessive antibiotic use for respiratory infections in the United States
10. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics
11. Tylenol cold tablets (acetaminophen, chlorpheniramine, pseudoephedrine)
12. Interethnic differences of drug-metabolizing enzymes
13. Acute liver failure; clinical features and management
14. Nyquil-associated liver injury
15. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults
16. A controlled study of the effect of oral penicillin G in the treatment of non-specific upper respiratory infections
17. Antibiotics and chemotherapeutic agents in the treatment of uncomplicated respiratory infections in children
18. Chemoprophylaxis during respiratory infection in private practice
19. Prevention of complications of respiratory illnesses in a pediatric practice
20. Evaluation of orally administered antibiotics for treatment of upper respiratory infections in Thai children
21. The value of antibiotics in minor respiratory illness in children. A controlled trial
22. Randomised controlled trial of antibiotics in patients with cough and purulent sputum
23. Amoxycillin and cotrimoxazole in presumed viral respiratory infections of childhood: Placebo-controlled trial
24. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions
25. Systematic review of the treatment of upper respiratory tract infection
26. Potential interventions for preventing pneumonia among young children: Lack of effect of antibiotic treatment for upper respiratory infections
27. Bacteriology and treatment of purulent nasopharyngitis: A double blind, placebo-controlled evaluation
28. The responsibility of the infectious disease community for the optimal use of antimicrobial agents
29. Antimicrobial prescribing for acute purulent rhinitis in children: A survey of pediatricians and family practitioners
30. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis
31. Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: A national study of hospital-based emergency departments
32. Acute respiratory infections: The forgotten pandemic. Communique from the International Conference on Acute Respiratory Infections, held in Canberra, Australia, 7-10 July 1997
33. Resistant pneumococci: Protecting patients through judicious use of antibiotics
34. The crisis in antibiotic resistance
35. Bug/drug resistance. Sometimes less is more
36. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY antimicrobial surveillance program
37. Three year global experience of the SENTRY antimicrobial surveillance program (1997-99) monitoring community-acquired respiratory tract infection (CARTI) pathogens: Results from 17,166 strains of S. pneumoniae (SPN), H. influenzae (HI), and M. catarrhalis (MCCAT)
38. Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States
39. The spread of multiply resistant Streptococcus pneumoniae at a daycare center in Ohio
40. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
41. Health and economic impacts of antimicrobial resistance
42. Current attitudes regarding use of antimicrobial agents: Results from physician's and parents' focus group discussions
43. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
44. Antibiotics prescription in primary care: A 5-year follow-up of an educational programme
45. Incorporating clinical outcomes and economic consequences into drug formulary decisions: A practical approach
46. Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies
47. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients
48. Clinical and financial benefits of rapid detection of respiratory viruses: An outcomes study